Pre-order Enquiry
Request Free Sample
Global RNAi for Therapeutic Market 2019 by Company, Regions, Type and Application, Forecast to 2024
SKU ID : GIR-13851207 | Publishing Date : 14-Feb-2019 | No. of pages : 115
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global RNAi for Therapeutic Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Table of Contents1 RNAi for Therapeutic Market Overview
1.1 Product Overview and Scope of RNAi for Therapeutic
1.2 Classification of RNAi for Therapeutic by Types
1.2.1 Global RNAi for Therapeutic Revenue Comparison by Types (2019-2024)
1.2.2 Global RNAi for Therapeutic Revenue Market Share by Types in 2018
1.2.3 siRNA
1.2.4 miRNA
1.2.5 shRNA
1.3 Global RNAi for Therapeutic Market by Application
1.3.1 Global RNAi for Therapeutic Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.3.5 Other
1.4 Global RNAi for Therapeutic Market by Regions
1.4.1 Global RNAi for Therapeutic Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) RNAi for Therapeutic Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) RNAi for Therapeutic Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNAi for Therapeutic Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) RNAi for Therapeutic Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) RNAi for Therapeutic Status and Prospect (2014-2024)
1.5 Global Market Size of RNAi for Therapeutic (2014-2024)
2 Manufacturers Profiles
2.1 Alnylam Pharmaceuticals
2.1.1 Business Overview
2.1.2 RNAi for Therapeutic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.2 Arbutus Biopharma (Tekmira)
2.2.1 Business Overview
2.2.2 RNAi for Therapeutic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.3 Arrowhead
2.3.1 Business Overview
2.3.2 RNAi for Therapeutic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Arrowhead RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.4 Dicerna Pharmaceuticals
2.4.1 Business Overview
2.4.2 RNAi for Therapeutic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.5 Mirna Therapeutics
2.5.1 Business Overview
2.5.2 RNAi for Therapeutic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mirna Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.6 Quark Pharmaceuticals
2.6.1 Business Overview
2.6.2 RNAi for Therapeutic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Quark Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.7 RXi Pharmaceuticals
2.7.1 Business Overview
2.7.2 RNAi for Therapeutic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 RXi Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.8 Silence Therapeutics
2.8.1 Business Overview
2.8.2 RNAi for Therapeutic Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Silence Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.9 Benitec Biopharma
2.9.1 Business Overview
2.9.2 RNAi for Therapeutic Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Benitec Biopharma RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.10 miRagen Therapeutics
2.10.1 Business Overview
2.10.2 RNAi for Therapeutic Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 miRagen Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.11 Sylentis
2.11.1 Business Overview
2.11.2 RNAi for Therapeutic Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sylentis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.12 Gradalis
2.12.1 Business Overview
2.12.2 RNAi for Therapeutic Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Gradalis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.13 Sirnaomics
2.13.1 Business Overview
2.13.2 RNAi for Therapeutic Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sirnaomics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.14 Silenseed
2.14.1 Business Overview
2.14.2 RNAi for Therapeutic Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Silenseed RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
3 Global RNAi for Therapeutic Market Competition, by Players
3.1 Global RNAi for Therapeutic Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 RNAi for Therapeutic Players Market Share
3.2.2 Top 10 RNAi for Therapeutic Players Market Share
3.3 Market Competition Trend
4 Global RNAi for Therapeutic Market Size by Regions
4.1 Global RNAi for Therapeutic Revenue and Market Share by Regions
4.2 North America RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
4.3 Europe RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
4.5 South America RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
5 North America RNAi for Therapeutic Revenue by Countries
5.1 North America RNAi for Therapeutic Revenue by Countries (2014-2019)
5.2 USA RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
5.3 Canada RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
5.4 Mexico RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
6 Europe RNAi for Therapeutic Revenue by Countries
6.1 Europe RNAi for Therapeutic Revenue by Countries (2014-2019)
6.2 Germany RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
6.3 UK RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
6.4 France RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
6.5 Russia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
6.6 Italy RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
7 Asia-Pacific RNAi for Therapeutic Revenue by Countries
7.1 Asia-Pacific RNAi for Therapeutic Revenue by Countries (2014-2019)
7.2 China RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
7.3 Japan RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
7.4 Korea RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
7.5 India RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
8 South America RNAi for Therapeutic Revenue by Countries
8.1 South America RNAi for Therapeutic Revenue by Countries (2014-2019)
8.2 Brazil RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
8.3 Argentina RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
8.4 Colombia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue RNAi for Therapeutic by Countries
9.1 Middle East and Africa RNAi for Therapeutic Revenue by Countries (2014-2019)
9.2 Saudi Arabia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
9.3 UAE RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
9.4 Egypt RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
9.5 Nigeria RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
9.6 South Africa RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
10 Global RNAi for Therapeutic Market Segment by Type
10.1 Global RNAi for Therapeutic Revenue and Market Share by Type (2014-2019)
10.2 Global RNAi for Therapeutic Market Forecast by Type (2019-2024)
10.3 siRNA Revenue Growth Rate (2014-2024)
10.4 miRNA Revenue Growth Rate (2014-2024)
10.5 shRNA Revenue Growth Rate (2014-2024)
11 Global RNAi for Therapeutic Market Segment by Application
11.1 Global RNAi for Therapeutic Revenue Market Share by Application (2014-2019)
11.2 RNAi for Therapeutic Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2014-2019)
11.4 Cardiovascular Revenue Growth (2014-2019)
11.5 HBV Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global RNAi for Therapeutic Market Size Forecast (2019-2024)
12.1 Global RNAi for Therapeutic Market Size Forecast (2019-2024)
12.2 Global RNAi for Therapeutic Market Forecast by Regions (2019-2024)
12.3 North America RNAi for Therapeutic Revenue Market Forecast (2019-2024)
12.4 Europe RNAi for Therapeutic Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific RNAi for Therapeutic Revenue Market Forecast (2019-2024)
12.6 South America RNAi for Therapeutic Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa RNAi for Therapeutic Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Figures, Tables and Charts Available in Global RNAi for Therapeutic Market 2019 by Company, Regions, Type and Application, Forecast to 2024
List of Tables and FiguresFigure RNAi for Therapeutic Picture
Table Product Specifications of RNAi for Therapeutic
Table Global RNAi for Therapeutic and Revenue (Million USD) Market Split by Product Type
Figure Global RNAi for Therapeutic Revenue Market Share by Types in 2018
Figure siRNA Picture
Figure miRNA Picture
Figure shRNA Picture
Table Global RNAi for Therapeutic Revenue (Million USD) by Application (2014-2024)
Figure RNAi for Therapeutic Revenue Market Share by Applications in 2018
Figure Cancer Picture
Figure Cardiovascular Picture
Figure HBV Picture
Figure Other Picture
Table Global Market RNAi for Therapeutic Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alnylam Pharmaceuticals RNAi for Therapeutic Type and Applications
Table Alnylam Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Arbutus Biopharma (Tekmira) Basic Information, Manufacturing Base and Competitors
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Type and Applications
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Arrowhead Basic Information, Manufacturing Base and Competitors
Table Arrowhead RNAi for Therapeutic Type and Applications
Table Arrowhead RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Dicerna Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Dicerna Pharmaceuticals RNAi for Therapeutic Type and Applications
Table Dicerna Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Mirna Therapeutics Basic Information, Manufacturing Base and Competitors
Table Mirna Therapeutics RNAi for Therapeutic Type and Applications
Table Mirna Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Quark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Quark Pharmaceuticals RNAi for Therapeutic Type and Applications
Table Quark Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table RXi Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table RXi Pharmaceuticals RNAi for Therapeutic Type and Applications
Table RXi Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Silence Therapeutics Basic Information, Manufacturing Base and Competitors
Table Silence Therapeutics RNAi for Therapeutic Type and Applications
Table Silence Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Benitec Biopharma Basic Information, Manufacturing Base and Competitors
Table Benitec Biopharma RNAi for Therapeutic Type and Applications
Table Benitec Biopharma RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table miRagen Therapeutics Basic Information, Manufacturing Base and Competitors
Table miRagen Therapeutics RNAi for Therapeutic Type and Applications
Table miRagen Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Sylentis Basic Information, Manufacturing Base and Competitors
Table Sylentis RNAi for Therapeutic Type and Applications
Table Sylentis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Gradalis Basic Information, Manufacturing Base and Competitors
Table Gradalis RNAi for Therapeutic Type and Applications
Table Gradalis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Sirnaomics Basic Information, Manufacturing Base and Competitors
Table Sirnaomics RNAi for Therapeutic Type and Applications
Table Sirnaomics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Silenseed Basic Information, Manufacturing Base and Competitors
Table Silenseed RNAi for Therapeutic Type and Applications
Table Silenseed RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Global RNAi for Therapeutic Revenue (Million USD) by Players (2014-2019)
Table Global RNAi for Therapeutic Revenue Share by Players (2014-2019)
Figure Global RNAi for Therapeutic Revenue Share by Players in 2017
Figure Global RNAi for Therapeutic Revenue Share by Players in 2018
Figure Global Top 5 Players RNAi for Therapeutic Revenue Market Share in 2018
Figure Global Top 10 Players RNAi for Therapeutic Revenue Market Share in 2018
Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global RNAi for Therapeutic Revenue (Million USD) by Regions (2014-2019)
Table Global RNAi for Therapeutic Revenue Market Share by Regions (2014-2019)
Figure Global RNAi for Therapeutic Revenue Market Share by Regions (2014-2019)
Figure Global RNAi for Therapeutic Revenue Market Share by Regions in 2018
Figure North America RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Europe RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure South America RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Table North America RNAi for Therapeutic Revenue by Countries (2014-2019)
Table North America RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure North America RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure North America RNAi for Therapeutic Revenue Market Share by Countries in 2018
Figure USA RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Canada RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Mexico RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Table Europe RNAi for Therapeutic Revenue (Million USD) by Countries (2014-2019)
Figure Europe RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Europe RNAi for Therapeutic Revenue Market Share by Countries in 2018
Figure Germany RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure UK RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure France RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Russia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Italy RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Table Asia-Pacific RNAi for Therapeutic Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Share by Countries in 2018
Figure China RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Japan RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Korea RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure India RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Table South America RNAi for Therapeutic Revenue by Countries (2014-2019)
Table South America RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure South America RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure South America RNAi for Therapeutic Revenue Market Share by Countries in 2018
Figure Brazil RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Argentina RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Colombia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Table Middle East and Africa RNAi for Therapeutic Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa RNAi for Therapeutic Revenue Market Share by Countries in 2018
Figure Saudi Arabia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure UAE RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Egypt RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Nigeria RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure South Africa RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Table Global RNAi for Therapeutic Revenue (Million USD) by Type (2014-2019)
Table Global RNAi for Therapeutic Revenue Share by Type (2014-2019)
Figure Global RNAi for Therapeutic Revenue Share by Type (2014-2019)
Figure Global RNAi for Therapeutic Revenue Share by Type in 2019
Table Global RNAi for Therapeutic Revenue Forecast by Type (2019-2024)
Figure Global RNAi for Therapeutic Market Share Forecast by Type (2019-2024)
Figure Global siRNA Revenue Growth Rate (2014-2019)
Figure Global miRNA Revenue Growth Rate (2014-2019)
Figure Global shRNA Revenue Growth Rate (2014-2019)
Table Global RNAi for Therapeutic Revenue by Application (2014-2019)
Table Global RNAi for Therapeutic Revenue Share by Application (2014-2019)
Figure Global RNAi for Therapeutic Revenue Share by Application (2014-2019)
Figure Global RNAi for Therapeutic Revenue Share by Application in 2019
Table Global RNAi for Therapeutic Revenue Forecast by Application (2019-2024)
Figure Global RNAi for Therapeutic Market Share Forecast by Application (2019-2024)
Figure Global Cancer Revenue Growth Rate (2014-2019)
Figure Global Cardiovascular Revenue Growth Rate (2014-2019)
Figure Global HBV Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global RNAi for Therapeutic Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global RNAi for Therapeutic Revenue Market Share Forecast by Regions (2019-2024)
Figure North America RNAi for Therapeutic Revenue Market Forecast (2019-2024)
Figure Europe RNAi for Therapeutic Revenue Market Forecast (2019-2024)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Forecast (2019-2024)
Figure South America RNAi for Therapeutic Revenue Market Forecast (2019-2024)
Figure Middle East and Africa RNAi for Therapeutic Revenue Market Forecast (2019-2024)
Keyplayers in Global RNAi for Therapeutic Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Alnylam PharmaceuticalsArbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed
